Lexaria Bioscience

LEXXNasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$7.215 M

$3.43 +5.71%

Close of 21 Sept 2026

Revenue

$705.9K

#3506 by revenue

Earnings

-$11.9M

Loss-making

Shares outstanding

24,787,446

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#448InMed PharmaceuticalsINM$7.58M
#449Acurx PharmaceuticalsACXP$7.39M
#450Lexaria BioscienceLEXX$7.21M
#451Xenetic BiosciencesXBIO$7.01M
#452Enveric BiosciencesENVB$6.98M

What if Lexaria Bioscience were worth as much as…

Open the what-if tool →

Gold $30.3T

$14,371,821

Per share 4,196,152× higher

Bitcoin $1.72T

$816,432.15

Per share 238,374× higher

Nvidia $5.48T

$2,601,420

Per share 759,539× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for Lexaria Bioscience are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.